May 30: World MS Day

It is currently difficult for a patient to accept that their form of multiple sclerosis does not yet have a satisfactory curative response. However, current MS research offers real prospects for the future. Proof of this are the numerous treatments that were not available twenty years ago.

What is the Charcot Foundation's contribution to this progress?

Thanks to donors, we can reinvest every year in Belgian university research teams within the Fonds Charcot. The selection of this innovative research is rigorous and is entrusted to a team of Belgian and foreign experts.

‍